Search
Hydracarbazine
go.drugbank.com/drugs/DB09243ExperimentalHydracarbazine is a pyridazine that has found use as an antihypertensive agent [A19790] It was once marketed in France under the tradename Normatensyl.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeD-threo-neopterin
go.drugbank.com/drugs/DB02385ExperimentalA pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections.
Categories: Enzymes and CoenzymesBivatuzumab
go.drugbank.com/drugs/DB06550InvestigationalBivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.
Categories: Amino Acids, Peptides, and ProteinsLabradimil
go.drugbank.com/drugs/DB06549InvestigationalCategories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and ProteinsProquazone
go.drugbank.com/drugs/DB13649ExperimentalCategories: Antiinflammatory and Antirheumatic Products, Non-Steroids, Antiinflammatory and Antirheumatic ProductsNTx-265
go.drugbank.com/drugs/DB05649InvestigationalNTx-265 is a combination of two currently marketed large molecules designed to stimulate the growth and differentiation of neural stem cells in adults who have suffered a stroke – the second leading cause … It is also investigating use of the compound for neurodegenerative disorders, such as Huntington’s disease and Alzheimer’s disease.
Nizubaglustat
go.drugbank.com/drugs/DB21603InvestigationalNizubaglustat is under investigation in clinical trial NCT07054515 (A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type
Vicadrostat
go.drugbank.com/drugs/DB21693InvestigationalVicadrostat is under investigation in clinical trial NCT07064473 (A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular … The usage of the INN stem '-drostat' in the name indicates that Vicadrostat is a inhibitor of the synthesis of aldosterone and cortisol.
Anti-GD2 monoclonal antibody 3F8
go.drugbank.com/drugs/DB15388InvestigationalAnti-GD2 monoclonal antibody 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).